The valve gets fixed. The risk doesn't disappear.
TAVR has transformed the treatment of aortic stenosis. Procedural success rates are high and early mortality has fallen sharply — but a successful valve replacement does not guarantee a successful recovery.
Even after a technically flawless procedure, 20–25% of patients are readmitted within 90 days (Abramowitz et al., Circ Cardiovasc Interv 2017), and roughly two-thirds of deaths in this population are non-cardiac (Kolte et al., JACC Cardiovasc Interv 2025, n=36,877) — driven by infection and systemic decline that routine follow-up isn't structured to catch.
days of continuous monitoring from discharge
A repaired valve still leaves a patient exposed. BridgeCare LA enrolls every TAVR patient in continuous Clinical Status Monitoring the day they're discharged, whether or not they already look high-risk.
The program layers hemodynamic monitoring through Vivio, rhythm monitoring with an ECG patch across the first month and Kardia through day 90, and home-device tracking of weight, blood pressure, heart rate, SpO₂, and temperature against parameters the ordering physician defines — all reviewed by the physician across precisely the stretch where systemic decline tends to do the most harm while drawing the least scrutiny. Cardiac rhythm data collected by cleared cardiac devices is transmitted to the treating physician for clinical review — including findings related to atrial fibrillation, bradyarrhythmia patterns, and conduction-related measurements — and longitudinal daily data supports the physician in reviewing trends in patient status across monitoring periods.
Physician-defined laboratory parameters, alongside continuous temperature monitoring, are reviewed by the ordering physician — usually pulled from labs the patient is already scheduled for, so nothing extra is ordered.
Continuous device-based temperature monitoring alongside physician-defined laboratory parameter monitoring — both reviewed by the ordering physician, rather than relying on either alone.
TAVR solves the valve. BridgeCare LA extends the visibility, narrows the uncertainty, and makes earlier intervention possible — for everything that comes after.
Deploy this program across Louisiana.
Talk to BridgeCare LA about bringing Post-TAVR Monitoring to your practice or health system.
Book a Consultation